The Top Line Automation, decentralization and the future of CAR-Ts: Advancements in cell & gene therapy manufacturing (Part III)
May 24, 2024
Bruce Levine, co-inventor of Kymriah, and industry experts discuss CAR-T therapies, infrastructure challenges, FDA warnings on T-cell cancers post-treatment, advancements in gene editing for heart patients, cost-effective manufacturing strategies, and G-Rex technology for optimized cell production.
Chapters
Transcript
Episode notes
1 2 3 4 5 6
Introduction
00:00 • 2min
Evolving Challenges in Cell and Gene Therapy Manufacturing
01:35 • 16min
Risks and Uncertainties in CAR-T Treatment: Secondary T-cell Malignancies
17:59 • 4min
Advancements in Gene Editing Therapies and Cell Manufacturing for Heart Patients
22:23 • 9min
Maximizing Efficiency and Cost-Effectiveness in Cell and Gene Therapy Manufacturing
31:11 • 4min
In-depth exploration of G-Rex technology for cell and gene therapy manufacturing
34:50 • 5min